NCT04553133
A clinical trial of a study medicine for people with advanced ovarian cancer
The C4161001 study is researching whether a study medicine is safe and effective in the treatment of advanced ovarian cancer.
Unfortunately, current treatment options are limited and may not work for everyone. Doctors are working to find better treatment options for people living with advanced ovarian cancer.
Who may participate
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
Phone calls to check in every 2 months
Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.
About ovarian cancer
About ovarian cancer
Ovarian cancer is a group of diseases that originates in a women’s ovaries, or in the related areas of the fallopian tubes and the peritoneum (the tissue lining that covers organs in the abdomen). Ovarian cancers come in a variety of different tumor types. The most common tumor type is high-grade serous carcinoma, accounting for about 70% of ovarian cancer cases.
Frequently asked questions
How long will I be in the study?
Time in the study will vary for everyone and depends on how your cancer responds to the study medicine. You may continue to receive the study medicine for as long as it is benefiting you. After completing the course of study medicine, you will need to continue with long term follow-up every two months.
What are the benefits and risks?
Your cancer may get better, get worse, or stay the same. Your health will be closely monitored during the study. Participation may help people in the future by increasing our understanding of the investigational or study medicine and ovarian cancer.
If your health gets worse, your study team and your study doctor will help you decide what to do, which may mean stopping your participation in the study. Potential risks from taking part in the study may include: side effects from taking the study medicine, for example diarrhea, nausea, fatigue; risks or discomforts from study procedures such as blood tests and body scans; risk of allergic reaction to the study medicine.
